Sanofi, Regeneron Expand Drug Partnership in $8 Billion Deal

Sanofi SA is expanding its long-running partnership with Regeneron Pharmaceuticals in a deal potentially worth $8 billion, strengthening the French drugmakers pipeline of treatments for inflammatory diseases beyond...